Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/408
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons
Description: Subject matter wherein the five-membered hetero ring consists of one nitrogen and four carbon atoms, e.g., pyrrolidine, etc.

Sub-classes under this class:

Class Number	Class Name	Patents
514/422	Additional hetero ring	1,660
514/423	C=x bonded directly to the five-membered hetero ring by nonionic bonding (x is chalcogen)	1,285
514/429	Carbocyclic ring bonded directly to the five-membered hetero ring	220
514/424	Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding	630
514/428	Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding	816
514/426	Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding	256
514/410	Polycyclo ring system having the five-membered hetero ring as one of the cyclos	563
514/409	Spiro ring system	281
514/427	Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)	473

Patents under this class:

1 2 3 4 5 6 7 8 9 10 11 12

Patent Number	Title Of Patent	Date Issued
6306848	Method of modifying wrinkles using guanidine derivatives	Oct. 23, 2001
6306912	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases	Oct. 23, 2001
6294569	Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists	Sep. 25, 2001
6294551	N-linked sulfonamides of heterocyclic thioesters	Sep. 25, 2001
6284784	Substituted 2-pyrrolidinone activators of PKC	Sep. 4, 2001
6281206	Amidino protease inhibitors	Aug. 28, 2001
6274613	Cyclic imines as pesticides	Aug. 14, 2001
6268377	Method for treating androgen-related conditions	Jul. 31, 2001
6265431	Cycloalkano-indole and -azaindole derivatives	Jul. 24, 2001
6265434	Pyrrolidine modulators of chemokine receptor activity	Jul. 24, 2001
6262101	Immunotherapeutic agents	Jul. 17, 2001
6262104	Diarylalkenylamine derivatives	Jul. 17, 2001
6251931	Inhibitors of gap junction communication	Jun. 26, 2001
6231849	Simulated seminal fluid	May. 15, 2001
6225333	Method of treatment of pigmented cancer cells utilizing photodynamic therapy	May. 1, 2001
6214831	Pharmaceutical composition containing evodiamine compound and method for improving lipid metabolism or antiobesity	Apr. 10, 2001
6204286	Estrogen agonists/antagonists	Mar. 20, 2001
6200982	Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands	Mar. 13, 2001
6201017	Ectoparasite controlling agent for animals	Mar. 13, 2001
6180133	Antioxidant composition for topical/transdermal prevention and treatment of wrinkles	Jan. 30, 2001
6174879	Aminocyclohexylesters and uses thereof	Jan. 16, 2001
6166074	Pharmaceutical compositions	Dec. 26, 2000
6166013	Glucocortiocoid-selective agents	Dec. 26, 2000
6159983	Method and composition for treatment of inflammatory bowel disease	Dec. 12, 2000
6153624	Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders	Nov. 28, 2000
6140321	Polymorphs of donepezil hydrochloride and process for production	Oct. 31, 2000
6140356	Opthalmic pharmaceutical compositions comprising a nitrone compound and methods for treating ocular inflammation using such compositions	Oct. 31, 2000
6136803	Antidepressants	Oct. 24, 2000
6127400	Salts of diamine pyrrolidine	Oct. 3, 2000
6124277	Antithrombotic agents	Sep. 26, 2000
6121289	Method for enhanced brain delivery of nicotinic antagonist	Sep. 19, 2000
6103740	Methods for lowering platelet counts	Aug. 15, 2000
6100234	Treatment of HIV	Aug. 8, 2000
6100253	Tricycle substituted with azaheterocyclic carboxylic acids	Aug. 8, 2000
6071970	Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases	Jun. 6, 2000
6071944	Method of treatment of pigmented cancer cells utilizing photodynamic therapy	Jun. 6, 2000
6051573	Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists	Apr. 18, 2000
6051598	Amino ceramide-like compounds and therapeutic methods of use	Apr. 18, 2000
6048877	Tetralone derivatives as antiarrhythmic agents	Apr. 11, 2000
6040332	Amino ceramide-like compounds and therapeutic methods of use	Mar. 21, 2000
6040330	Pharmaceutical formulations of taxanes	Mar. 21, 2000
6040318	Tricycle substituted with azaheterocyclic carboxylic acids	Mar. 21, 2000
6034081	Potentiation of biocide activity using an N-alkyl heterocyclic compound	Mar. 7, 2000
6030971	Methods and compositions for controlling biofouling using amides	Feb. 29, 2000
6025381	Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease	Feb. 15, 2000
6017946	Serotonin containing formulation for oral administration and method of use	Jan. 25, 2000
6015811	Antitumor Chrysene derivatives	Jan. 18, 2000
6013656	2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors	Jan. 11, 2000
6011057	Methods for inhibiting uterine fibroid disease	Jan. 4, 2000
6008244	Halopropargyl compounds as marine antifouling agents	Dec. 28, 1999